158 related articles for article (PubMed ID: 7729781)
21. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
22. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the possible role of iron and copper in cisplatin-induced nephrotoxicity in the rat.
Goudie J; Chandra M; Lawrence GD; Williams P
Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):33-49. PubMed ID: 8165368
[TBL] [Abstract][Full Text] [Related]
24. Methylprednisolone reduces the nephrotoxicity caused by cisplatin.
Uozumi J; Koikawa Y; Ueda T
J Pharmacobiodyn; 1992 Dec; 15(12):693-7. PubMed ID: 1296980
[TBL] [Abstract][Full Text] [Related]
25. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats.
Borrego A; Zamora ZB; González R; Romay C; Menéndez S; Hernández F; Montero T; Rojas E
Mediators Inflamm; 2004 Feb; 13(1):13-9. PubMed ID: 15203559
[TBL] [Abstract][Full Text] [Related]
26. Effects of cisplatin-induced nephrotoxicity on gentamicin pharmacokinetics in rats.
Engineer MS; Bodey GP; Newman RA; Ho DH
Drug Metab Dispos; 1987; 15(3):329-34. PubMed ID: 2886307
[TBL] [Abstract][Full Text] [Related]
27. Amelioration of cisplatin-induced nephrotoxicity in rats by tetramethylpyrazine, a major constituent of the Chinese herb Ligusticum wallichi.
Ali BH; Al-Moundhri M; Eldin MT; Nemmar A; Al-Siyabi S; Annamalai K
Exp Biol Med (Maywood); 2008 Jul; 233(7):891-6. PubMed ID: 18445776
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of captopril against cisplatin-induced nephrotoxicity in rats.
El-Sayed el-SM; Abd-Ellah MF; Attia SM
Pak J Pharm Sci; 2008 Jul; 21(3):255-61. PubMed ID: 18614421
[TBL] [Abstract][Full Text] [Related]
29. The protective effect of methylprednisolone against cisplatin-induced nephrotoxicity in patients with urothelial tumors.
Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Kumazawa J
Int J Urol; 1996 Sep; 3(5):343-7. PubMed ID: 8886909
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
31. [Experimental study of protective effect of solcoseryl on cisplatin nephrotoxicity].
Satoh H; Mori Y
Gan To Kagaku Ryoho; 1992 Jan; 19(1):89-93. PubMed ID: 1729962
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
33. Serum thymic factor, FTS, attenuates cisplatin nephrotoxicity by suppressing cisplatin-induced ERK activation.
Kohda Y; Kawai Y; Iwamoto N; Matsunaga Y; Aiga H; Awaya A; Gemba M
Biochem Pharmacol; 2005 Nov; 70(9):1408-16. PubMed ID: 16154539
[TBL] [Abstract][Full Text] [Related]
34. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats.
Karahan I; Ateşşahin A; Yilmaz S; Ceribaşi AO; Sakin F
Toxicology; 2005 Nov; 215(3):198-204. PubMed ID: 16125832
[TBL] [Abstract][Full Text] [Related]
36. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
Nagai N; Hotta K; Yamamura H; Ogata H
Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between plasma and urinary platinum pharmacokinetics with cisplatin nephrotoxicity in breast cancer patients].
Guo JH
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):150-3. PubMed ID: 1618086
[TBL] [Abstract][Full Text] [Related]
38. Early and quantitative detection of cisplatin-induced nephrotoxicity by measurement of plasma PSP (phenolsulfonphthalein) half-life in rats.
Uozumi J; Ueda T; Koikawa Y; Yasumasu T; Kumazawa J
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):901-4. PubMed ID: 8254999
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.
Hanigan MH; Gallagher BC; Taylor PT; Large MK
Cancer Res; 1994 Nov; 54(22):5925-9. PubMed ID: 7954424
[TBL] [Abstract][Full Text] [Related]
40. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
Yamada T
Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
